By Michele Maatouk
Date: Wednesday 31 Dec 2025
(Sharecast News) - Vanda Pharmaceuticals shares rocketed on Wednesday after the US Food and Drug Administration approved its motion sickness drug.
No recent information was found.
| AstraZeneca is sued over asthma drug deal | 27-May-2009 | LA Times |
| Local Digest | 09-May-2009 | Washington Post |
| Local Digest | 08-May-2009 | Washington Post |
| Local Briefing | 12-Feb-2009 | Washington Post |
| Local Briefing | 31-Oct-2008 | Washington Post |
| Thursday's market movers | 09-May-2009 | Chicago Tribune |
| Stocks slip ahead of November jobs data | 08-Dec-2006 | Wall Street Journal |
| Dow ends down 31 ahead of jobs report | 08-Dec-2006 | BayArea.com |
| Test of Insomnia Drug Bolsters Vanda's Plan | 16-Nov-2006 | Washington Post |
No recent information was found.
| Currency | US Dollars |
| Share Price | $ 8.25 |
| Change Today | $ -0.57 |
| % Change | -6.46 % |
| 52 Week High | $8.74 |
| 52 Week Low | $7.93 |
| Volume | 4,941,022 |
| Shares Issued | 52.38m |
| Market Cap | $432.13m |
| RiskGrade | 297 |
| Strong Buy | 0 |
| Buy | 3 |
| Neutral | 1 |
| Sell | 0 |
| Strong Sell | 0 |
| Total | 4 |

| Time | Volume / Share Price |
| 15:59 | 100 @ $8.25 |
| 15:59 | 591 @ $8.25 |
| 15:59 | 300 @ $8.25 |
| 15:59 | 100 @ $8.25 |
| 15:59 | 100 @ $8.25 |
You are here: research